Clinical research evaluates pharmaceuticals, devices, and treatments to ensure they are safe and effective before being made available to the public.

Clinical trials typically progress through four main phases, each serving distinct purposes and objectives:

Phase 1: Phase 1 trials focus on assessing the safety and tolerability of a treatment.

Phase 2: Phase 2 trials further evaluate the safety and efficacy of the investigational drug.

Phase 3: Phase 3 trials are large-scale studies designed to confirm the efficacy and safety of the investigational drug compared to standard treatment.

Phase 4: Phase 4 trials, also known as post-marketing or surveillance studies, occur after the drug has been approved for marketing and is available to the general population.

Advancements in healthcare depend on clinical research to introduce new treatments, devices, and medications to the public. This research drives progress in public health by improving disease prevention, diagnosis, and treatment strategies. By testing new approaches through clinical trials, we can reduce the impact of illness and disability, ultimately leading to healthier communities and improved lives.

Are you interested in participating in paid clinical trials? If so, you can explore our list of research studies and locations. If you find a study that interests you,  fill out the form on the study page, and a member of our research staff will contact you to see if you qualify.

An Investigational Drug or Investigational Device refers to a pharmaceutical substance (such as a drug) or a medical device (such as a pacemaker) being studied in clinical trials to evaluate its safety, efficacy, and potential benefits for treating a specific disease or medical condition.